# Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension

> **NCT00367094** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 296 (—)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Benazepril plus hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00367094
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 296 (—)
- **Last updated:** 2007-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00367094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00367094, "Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00367094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*